Market Overview

Top 4 Large-Cap Stocks In The Biotechnology Industry With The Lowest PEG Ratio

Related GILD
These 2 Biotech Stocks Are Set To Split The $15 Billion Hepatitis C Market
Gilead Sciences Bucks Trend In Biotech Short Interest
Gilead, Price Controls' Supporting Role in the Midterms (Fox Business)
Related CELG
#PreMarket Primer: Monday, December 15: Hostages Taken In Downtown Sydney
Gilead Sciences Bucks Trend In Biotech Short Interest
Yellen Swats Down Biotech, Social Media Stocks (Fox Business)

Below are the top large-cap biotechnology stocks on the NYSE and the NASDAQ in terms of PEG ratio.

Gilead Sciences (NASDAQ: GILD) has a PEG ratio of 0.62. Gilead Sciences' trailing-twelve-month revenue is $11.20 billion.

Celgene (NASDAQ: CELG) has a PEG ratio of 0.93. Celgene's trailing-twelve-month operating margin is 30.49%.

Alexion Pharmaceuticals (NASDAQ: ALXN) has a PEG ratio of 1.63. Alexion Pharma's trailing-twelve-month EPS is $1.27.

Biogen Idec (NASDAQ: BIIB) has a PEG ratio 1.67. Biogen Idec's trailing-twelve-month ROE is 23.90%.

Posted-In: Biotechnology Industry Large-Cap PEG ratioTrading Ideas

 

Related Articles (ALXN + BIIB)

Around the Web, We're Loving...

Get Benzinga's Newsletters